SUBCUTANEOUS OUTPATIENT MANAGEMENT

  • US 20160117481A1
  • Filed: 10/26/2015
  • Published: 04/28/2016
  • Est. Priority Date: 10/27/2014
  • Status: Active Grant
First Claim
Patent Images

1. A method comprising:

  • receiving, at data processing hardware, subcutaneous information for a patient;

    executing, at the data processing hardware, a subcutaneous outpatient program for determining recommended insulin dosages, the subcutaneous outpatient program comprising;

    obtaining, at the data processing hardware, blood glucose data of the patient from a glucometer in communication with the computing device, the blood glucose data including blood glucose measurements of the patient, blood glucose times associated with the blood glucose measurements, and insulin dosages administered by the patient and associated with the blood glucose measurements;

    determining, by the data processing hardware, scheduled blood glucose time intervals associated with the blood glucose measurements based on the blood glucose times;

    aggregating, by the data processing hardware, the blood glucose measurements associated with at least one of the scheduled blood glucose time intervals to determine a representative aggregate blood glucose measurement associated with the at least one scheduled blood glucose time interval;

    determining, by the data processing hardware, a next recommended insulin dosage for the patient based on the representative aggregate blood glucose measurement and the subcutaneous information; and

    transmitting the next recommended insulin dosage from the data processing hardware to a portable device associated with the patient, the portable device displaying the next recommended insulin dosage.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×